Virpax Pharmaceuticals

View the org chart displaying its 10 main executives

Most searched biographies at Virpax Pharmaceuticals

• Gerald Bruce, Chief Executive Officer
• Vanila Singh, Director
• Jerrold Sendrow, Director

Popular executive movements at Virpax Pharmaceuticals

• Anthony Mack, Chief Executive Officer and Chairman of the Board, has left the company  (posted on November 19 2023).
• Eric Floyd, who was Director, is promoted to Chairman of the Board  (posted on November 19 2023).
• Gerald Bruce, who was Executive Vice President, Commercial Operations, is promoted to Chief Executive Officer  (posted on November 19 2023).

Create your alert
to follow the executive moves at Virpax Pharmaceuticals.

Virpax Pharmaceuticals has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Danilo Cicmil - Supervisory Board Member at Galenika
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Virpax Pharmaceuticals

• Virpax Pharmaceuticals Enters into CRADA with the National Advisory Neurological Disorders and Stroke Council - MyChesCo
• Virpax plans three trials based on platform drug delivery systems in 2024
• Maxim Group Sticks to Their Buy Rating for Virpax Pharmaceuticals (VRPX) - TipRanks.com
• Maxim Group Reaffirms Their Buy Rating on Virpax Pharmaceuticals (VRPX)
• Virpax Completes FDA Required Preclinical Toxicology Studies For Its Licensed Molecular Envelope Technology - Virpax Pharmaceuticals (NASDAQ:VRPX)
• Press Releases | Virpax Pharmaceuticals
• Altasciences Chosen by Virpax Pharmaceuticals, Inc. to Conduct First-in-Human Study of Epoladerm™ for Chronic Pain Associated with Osteoarthritis of the Knee | Altasciences
• Virpax Pharmaceuticals Selects Kindeva Drug Delivery as Development Partner for Diclofenac pMDI Commercialization | Kindeva Complex Drug CDMO
• News
• New CBD nasal spray to target seizures in epilepsy
• View more press releases Close

Social media about Virpax Pharmaceuticals

• Virpax Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Virpax Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including Barbara Ruskin

Call Virpax Pharmaceuticals at +1 610...

View the org chart

Register to receive your alert

Report an error